cofetuzumab pelidotin development code experimental antibodydrug conjugate development treatment cancer created stemcentrx developed drug monoclonal antibody linked auristatin microtubule antibodydrug conjugates use monoclonal antibody binds tumors cells linked cytotoxic drug kills cells allows drug selectively target cells antibody binds tocitation needed expressed many tumors including ovarian cancer breast cancer nonsmall cell lung early clinical trial results show response rate patients triple negative breast cancer almost complete response ovarian tumors resistant platinumbased httpsenwikipediaorgwikicofetuzumabpelidotin